Zoll wins supply contract with Universal Health Services:
This article was originally published in Clinica
Executive Summary
Zoll Medical has secured a three-year, sole source contract with Universal Health Services (UHS), ensuring the sale of its defibrillator line to the 100-plus medical facilities managed by UHS. "Centralising the purchasing process with UHS streamlines our sales cycles and builds on the success of our M Series defibrillators," said Richard Packer, president of the Chelmsford, Massachusetts firm. He also added that the deal enables it to expand the market for the company's latest product, the automated external defibrillator AED Plus, which boasts voice and visual prompting capabilities.
You may also be interested in...
Simplified Clinical Trial Transparency Rules To Go Live In The EU In June
A new version of the EU Clinical Trials Information System’s public portal will integrate the functionalities of the streamlined transparency rules.
Top-Selling Drugs 2023: Pharma’s $60bn COVID-19 Cliff
Pfizer/BioNTech’s COVID-19 vaccine Comirnaty toppled after recording the highest ever annual sales for a pharmaceutical in 2022, while Novo Nordisk’s Ozempic climbed rapidly. But Merck & Co’s immuno-oncology blockbuster Keytruda was secure in the number one spot in 2023 as COVID-19 receded.
Changes To EU Pharma Reform: More Questions Than Answers?
In the first of a series of articles on the future direction of the EU pharmaceutical reform proposals, the Pink Sheet looks at the new uncertainties created for the drug industry after the European Parliament voted through a series of amendments in the area of regulatory data protection.